This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
3 Aug 2012

Insights on Regulatory, QbD and Formulation of Nano Medicines at Nano Suspensions India 2012

Taking place on 21-22 August 2012 at Fortune Select Manohar, Hyderabad, India, this conference will have domestic and international speakers share their expertise and experience on key aspects like various stabilizers, dissolution studies, surface characterisation techniques.

CPHI introduces Nano Suspensions India 2012 which will be focusing on the most relevant and pressing issues around regulatory, QbD, solubility, stability and efficient scale-up of nano medicines.

 

Taking place on 21-22 August 2012 at Fortune Select Manohar, Hyderabad, India, this conference will have domestic and international speakers share their expertise and experience on key aspects like various stabilizers, dissolution studies, surface characterisation techniques like PCS, LD, FEM and X-ray, homogenisation techniques and terminal/non-terminal sterilisation.

 

Day One is dedicated to identify technologies that help to choose required particle size, retain the chemical properties of nano particles, effective characterisation techniques and QbD tools. Day Two is

Related News